![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Liste des catégories
AlcoolismeAlzheimer Et ParkinsonAnalgésiquesAnti-inflammatoiresAntiallergiquesAntibiotiquesAnticonvulsivantsAntidépresseursAntifongiquesAntiparasitairesAntivirauxArthriteAsthmeCancerChirurgieCholestérolContraceptifsDiabèteDiurétiquesDysfonction érectileHypertension ArtérielleMaladies CardiovasculairesMigrainesObésitéOstéoporoseRelaxants MusculairesSanté FéminineSanté MasculineSoins De La PeauSoins Des YeuxTractus Gastro-intestinalTroubles MentauxTroubles NeurologiquesV I HVoies RespiratoiresVoies Urinaires 18 May 2012 15:25:50
Launch of anti-HIV drug Combivir generic a positive development for LupinLaunch of anti-HIV drug Combivir generic a positive development for Lupin Economic Times MUMBAI: The launch of generic of anti-HIV drug Combivir is a positive development for Lupin. However, besides the innovator, it will have to share the market with two other competitors viz. Teva and Aurobindo Pharma. The limited competition product has ... Expect strong growth from US in FY13-14: Lupin
18 May 2012 12:39:29
Aurobindo Pharma receives US FDA approvalAurobindo Pharma receives US FDA approval Express Pharma Lamivudine and Zidovudine tablets USP 150 300 mg is the generic equivalent of ViiV Healthcare Company's Combivir Tablets USP 150 300 mg and is indicated as part of antiretroviral (ARV) combination therapy for the treatment of Human Immunodeficiency ...
17 May 2012 09:58:33
Aurobindo gets USFDA nod for anti-HIV drugsAurobindo gets USFDA nod for anti-HIV drugs Hindu Business Line The tablets are the generic equivalent of ViiV Healthcare Company's Combivir tablets and are indicated for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children. The product, which was approved out of Unit VII formulations ...
16 May 2012 13:34:50
Nifty may stage a slow recovery: Wednesday Closing ReportNifty may stage a slow recovery: Wednesday Closing Report Moneylife Personal Finance site and magazine The tablets are the generic equivalent of ViiV Healthcare Company's Combivir tablets and are indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected persons. Aurobindo declined 0.52% to ...
16 May 2012 08:02:53
Lupin Launches Generic Combivir Tablets Zee News Lupin Launches Generic Combivir Tablets RTT News Lupin's Lamivudine and Zidovudine tablets are the AB-rated generic equivalent of Viiv Healthcare's Combivir tablets, 150mg 300mg. Lamivudine Zidovudine is a combination of two nucleoside analogue reverse transcriptase inhibitors and is indicted in ... Lupin, Aurobindo get US regulator nod for HIV drug Lupin, Aurobindo get FDA nod for HIV drug15 May 2012 17:33:19
This Positive Life: An Interview With Bernard Jackson msnbc.com This Positive Life: An Interview With Bernard Jackson TheBody.com My first regimen was Combivir (AZT 3TC) and Sustiva (efavirenz, Stocrin). One of the side effects that I know I dealt with a lot was the crazy, vivid dreams, and anxiety. It eventually passed. That's one of the things that I try to share with people, ... Op-ed: Riding Is Like Choosing to Live15 May 2012 13:08:18
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYLANDMARK HIV DRUG'S PATENT EXPIRES TODAY U-T San Diego The patent on the landmark HIV AIDS drug Combivir will expire today, but there's already a far-less expensive generic version of the drug on the market. The FDA approved Combivir (lamivudine zidovudine) in 1997, greatly changing the treatment of ...
14 May 2012 19:46:45
Patent expires of landmark HIV drug CombivirPatent expires of landmark HIV drug Combivir U-T San Diego The patent on the landmark HIV AIDS drug Combivir will expire on May 15, but there's already a far less expensive generic version of the drug on the market. The FDA approved Combivir (lamivudine zidovudine) in 1997, greatly changing the treatment of ...
|
|
Choose Your language:
Recherche sur le site
Testimonials
Cher monsieur,
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|Politique|Questions fréquentes|Testimonials|Contactez-nous|Sitemap |
|
|
|
|
| |